Ascendis Pharma A/S vs Domino's Pizza, Inc. — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while Domino's Pizza, Inc. trades at $356.34 (market cap $11.82B). The key difference: Ascendis Pharma A/S is the larger of the two by market cap, and Domino's Pizza, Inc. pays a 2.23% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | DPZ | |
|---|---|---|
Market Cap | $16.67B | $11.82B |
Sector | Health | Consumer Cyclical |
52-Week High | $277.18 | $467.30 |
52-Week Low | $189.74 | $282.89 |
Enterprise Value | $17.04B | $16.78B |
Dividend Yield | — | 2.23% |
Trailing returns across standard periods
Latest headlines on both assets
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →